Adlai Nortye Ltd. — Investor Relations & Filings
Filings indexed
69
across all filing types
Latest filing
2026-04-16
Foreign Filer Report
Country
KY
Cayman Islands
Listing
US
ANL
Adlai Nortye Ltd. is a global clinical-stage biopharmaceutical company focused on discovering and developing innovative cancer therapies. The company's pipeline is centered on two key areas: next-generation cancer immunotherapies and RAS-targeting therapies. Its immunotherapy candidates include AN8025, a tri-functional fusion protein designed as a T-cell and antigen-presenting cell modulator, and AN4005, an oral small-molecule PD-L1 inhibitor. For RAS-driven cancers, the company is advancing AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting antibody-drug conjugate (ADC) that delivers a potent pan-RAS(ON) inhibitor.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Adlai Nortye Ltd. (0001944552) (Filer) | 2026-04-16 | English | |
| SCHEDULE 13G Filing | 2026-02-11 | English | |
| SCHEDULE 13G/A Filing | 2026-02-09 | English | |
| 6-K Filing | 2026-02-03 | English | |
| Major Shareholding Notification 2026 | 2026-01-20 | English | |
| Major Shareholding Notification 2026 | 2026-01-16 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 34647674 | 6-K - Adlai Nortye Ltd. (0001944552) (Filer) | 2026-04-16 | English | ||
| 32238402 | SCHEDULE 13G Filing | 2026-02-11 | English | ||
| 32238365 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
| 32238360 | 6-K Filing | 2026-02-03 | English | ||
| 13615226 | Major Shareholding Notification 2026 | 2026-01-20 | English | ||
| 13615227 | Major Shareholding Notification 2026 | 2026-01-16 | English | ||
|
2025
9 filings
| |||||
| 13615228 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-29 | English | ||
| 13615229 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-29 | English | ||
| 13615230 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-03 | English | ||
| 13615231 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-22 | English | ||
| 13615232 | REGISTRATION STATEMENT | 2025-09-16 | English | ||
| 13615234 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-07-09 | English | ||
| 13615233 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-05-30 | English | ||
| 13615235 | AMENDMENT NO. 1 TO FORM 20-F | 2025-05-10 | English | ||
| 13615258 | ANNUAL REPORT | 2025-04-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
Adlai Nortye Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34439/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34439 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34439 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34439 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34439}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Adlai Nortye Ltd. (id: 34439)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.